In the latest market close, Enveric Biosciences, Inc. (ENVB) reached $0.93, with a -0.46% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.91%.

Detailed price information for Enveric Biosciences Inc (ENVB-Q) from The Globe and Mail including charting and trades.

The average one-year price target for Enveric Biosciences (NasdaqCM:ENVB) has been revised to $122.40 / share. This is an increase of 1,100.00% from the prior estimate of $10.20 dated September 27, ...

Enveric Biosciences (NASDAQ:ENVB) just reported results for the first quarter of 2024. Enveric Biosciences reported earnings per share of -61 cents. This was above the analyst estimate for EPS of ...

Enveric Biosciences ( (ENVB)) just unveiled an update. On or about January 9, 2026, Enveric Biosciences prepared new investor presentation materials that its management planned to post on the ...

Enveric Biosciences, Inc. ENVB has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent application pertaining to its EVM301 series of molecules being ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address ...